<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p5" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_5{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t2_5{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t3_5{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t4_5{left:341px;bottom:30px;}
#t5_5{left:348px;bottom:25px;letter-spacing:0.11px;}
#t6_5{left:377px;bottom:30px;}
#t7_5{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t8_5{left:540px;bottom:30px;}
#t9_5{left:546px;bottom:25px;letter-spacing:0.07px;}
#ta_5{left:996px;bottom:873px;letter-spacing:-0.1px;}
#tb_5{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#tc_5{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#td_5{left:1091px;bottom:28px;letter-spacing:0.24px;}
#te_5{left:36px;bottom:778px;letter-spacing:-0.12px;word-spacing:0.02px;}
#tf_5{left:36px;bottom:478px;letter-spacing:-0.12px;}
#tg_5{left:36px;bottom:460px;letter-spacing:-0.15px;word-spacing:0.05px;}
#th_5{left:42px;bottom:442px;}
#ti_5{left:59px;bottom:442px;letter-spacing:-0.1px;word-spacing:0.01px;}
#tj_5{left:58px;bottom:423px;letter-spacing:-0.1px;}
#tk_5{left:36px;bottom:405px;letter-spacing:-0.12px;}
#tl_5{left:36px;bottom:387px;}
#tm_5{left:47px;bottom:387px;letter-spacing:-0.09px;word-spacing:0.01px;}
#tn_5{left:577px;bottom:387px;letter-spacing:-0.09px;}
#to_5{left:36px;bottom:368px;}
#tp_5{left:47px;bottom:368px;letter-spacing:-0.11px;word-spacing:0.03px;}
#tq_5{left:42px;bottom:350px;}
#tr_5{left:59px;bottom:350px;letter-spacing:-0.1px;word-spacing:0.02px;}
#ts_5{left:42px;bottom:332px;}
#tt_5{left:59px;bottom:332px;letter-spacing:-0.11px;word-spacing:-0.01px;}
#tu_5{left:42px;bottom:313px;}
#tv_5{left:59px;bottom:313px;letter-spacing:-0.11px;word-spacing:-0.11px;}
#tw_5{left:42px;bottom:295px;}
#tx_5{left:59px;bottom:295px;letter-spacing:-0.13px;word-spacing:-0.08px;}
#ty_5{left:36px;bottom:277px;letter-spacing:-0.25px;}
#tz_5{left:36px;bottom:258px;letter-spacing:-0.1px;word-spacing:0.01px;}
#t10_5{left:42px;bottom:240px;}
#t11_5{left:59px;bottom:240px;letter-spacing:-0.1px;word-spacing:0.01px;}
#t12_5{left:36px;bottom:222px;letter-spacing:-0.13px;}
#t13_5{left:36px;bottom:203px;}
#t14_5{left:47px;bottom:203px;letter-spacing:-0.09px;word-spacing:0.01px;}
#t15_5{left:852px;bottom:203px;letter-spacing:-0.08px;}
#t16_5{left:1024px;bottom:203px;letter-spacing:-0.08px;}
#t17_5{left:47px;bottom:185px;letter-spacing:-0.14px;word-spacing:0.02px;}
#t18_5{left:47px;bottom:167px;letter-spacing:-0.1px;}
#t19_5{left:36px;bottom:148px;letter-spacing:-0.13px;}
#t1a_5{left:36px;bottom:130px;letter-spacing:-0.09px;}
#t1b_5{left:36px;bottom:112px;letter-spacing:-0.12px;}
#t1c_5{left:36px;bottom:93px;}
#t1d_5{left:47px;bottom:93px;letter-spacing:-0.09px;word-spacing:0.01px;}
#t1e_5{left:1090px;bottom:93px;}
#t1f_5{left:47px;bottom:75px;letter-spacing:-0.1px;word-spacing:0.02px;}
#t1g_5{left:35px;bottom:747px;letter-spacing:-0.11px;}
#t1h_5{left:35px;bottom:729px;letter-spacing:-0.09px;}
#t1i_5{left:35px;bottom:711px;letter-spacing:-0.09px;}
#t1j_5{left:540px;bottom:711px;letter-spacing:-0.09px;}
#t1k_5{left:630px;bottom:711px;letter-spacing:-0.08px;}
#t1l_5{left:35px;bottom:692px;letter-spacing:-0.09px;word-spacing:0.01px;}
#t1m_5{left:543px;bottom:692px;letter-spacing:-0.08px;}
#t1n_5{left:653px;bottom:692px;letter-spacing:-0.08px;}
#t1o_5{left:748px;bottom:692px;letter-spacing:-0.09px;}
#t1p_5{left:839px;bottom:692px;letter-spacing:-0.09px;}
#t1q_5{left:35px;bottom:674px;}
#t1r_5{left:46px;bottom:674px;letter-spacing:-0.12px;word-spacing:0.03px;}
#t1s_5{left:327px;bottom:674px;letter-spacing:-0.08px;}
#t1t_5{left:35px;bottom:656px;}
#t1u_5{left:46px;bottom:656px;letter-spacing:-0.09px;}
#t1v_5{left:46px;bottom:637px;letter-spacing:-0.09px;}
#t1w_5{left:232px;bottom:637px;letter-spacing:-0.09px;}
#t1x_5{left:35px;bottom:619px;}
#t1y_5{left:46px;bottom:619px;letter-spacing:-0.1px;word-spacing:0.02px;}
#t1z_5{left:924px;bottom:619px;letter-spacing:-0.08px;}
#t20_5{left:46px;bottom:601px;letter-spacing:-0.09px;}
#t21_5{left:127px;bottom:601px;letter-spacing:-0.09px;word-spacing:-0.04px;}
#t22_5{left:46px;bottom:582px;letter-spacing:-0.09px;word-spacing:-0.01px;}
#t23_5{left:46px;bottom:564px;letter-spacing:-0.09px;}
#t24_5{left:35px;bottom:546px;}
#t25_5{left:46px;bottom:546px;letter-spacing:-0.09px;}
#t26_5{left:46px;bottom:527px;letter-spacing:-0.08px;}
#t27_5{left:565px;bottom:527px;letter-spacing:-0.1px;word-spacing:0.02px;}
#t28_5{left:46px;bottom:509px;letter-spacing:-0.09px;}
#t29_5{left:1091px;bottom:59px;letter-spacing:-0.11px;}
#t2a_5{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_5{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_5{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s2_5{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s3_5{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s4_5{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s5_5{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s6_5{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s7_5{font-size:17px;font-family:Webdings_k6;color:#000;}
.s8_5{font-size:17px;font-family:ArialMT_k0;color:#000;}
.s9_5{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.sa_5{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts5" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg5Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg5" style="-webkit-user-select: none;"><object width="1210" height="935" data="5/5.svg" type="image/svg+xml" id="pdf5" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_5" class="t s0_5">NCCN Guidelines Version 4.2024 </span>
<span id="t2_5" class="t s0_5">Head and Neck Cancers </span>
<span id="t3_5" class="t s1_5">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t4_5" class="t s2_5">® </span>
<span id="t5_5" class="t s1_5">(NCCN </span>
<span id="t6_5" class="t s2_5">® </span>
<span id="t7_5" class="t s1_5">), All rights reserved. NCCN Guidelines </span>
<span id="t8_5" class="t s2_5">® </span>
<span id="t9_5" class="t s1_5">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="ta_5" class="t s3_5">NCCN Guidelines Index </span>
<span id="tb_5" class="t s3_5">Table of Contents </span>
<span id="tc_5" class="t s3_5">Discussion </span>
<span id="td_5" class="t s4_5">UPDATES </span>
<span id="te_5" class="t s4_5">Updates in Version 1.2024 of the NCCN Guidelines for Head and Neck Cancers from Version 2.2023 include: </span>
<span id="tf_5" class="t s5_5">OR-1 </span>
<span id="tg_5" class="t s6_5">• Workup </span>
<span id="th_5" class="t s7_5"></span><span id="ti_5" class="t s6_5">As clinically indicated, bullet added: Screening for hepatitis B (Also for ORPH-1, HYPO-1, NASO-1, GLOT-1, SUPRA-1, ETHM-1, MAXI-1, OCC-1, </span>
<span id="tj_5" class="t s6_5">SALI-1, MM-1) </span>
<span id="tk_5" class="t s5_5">OR-3 </span>
<span id="tl_5" class="t s6_5">• </span><span id="tm_5" class="t s8_5" data-mappings='[[21,"fi"],[65,"fi"]]'>Clinical Staging modiﬁed: Selected patients who decline or are unﬁt for </span><span id="tn_5" class="t s6_5">surgery </span>
<span id="to_5" class="t s6_5">• </span><span id="tp_5" class="t s8_5" data-mappings='[[51,"fi"]]'>Selected patients who decline surgery, pathway modiﬁed: </span>
<span id="tq_5" class="t s7_5"></span><span id="tr_5" class="t s8_5" data-mappings='[[53,"fi"],[70,"fi"]]'>Pathway removed: Concurrent systemic therapy/RT or Deﬁnitive RT (if unﬁt for concurrent systemic therapy/RT) </span>
<span id="ts_5" class="t s7_5"></span><span id="tt_5" class="t s6_5">Pathway removed: See Post Systemic Therapy/RT or RT Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="tu_5" class="t s7_5"></span><span id="tv_5" class="t s6_5">Pathway removed: Recurrent or persistent disease (See ADV-3) </span>
<span id="tw_5" class="t s7_5"></span><span id="tx_5" class="t s6_5">Follow-up added: Very Advanced Head and Neck Cancer (ADV-1) </span>
<span id="ty_5" class="t s5_5">ORPHPV-3 </span>
<span id="tz_5" class="t s6_5">• Induction chemotherapy (category 3) followed by RT or systemic therapy/RT </span>
<span id="t10_5" class="t s7_5"></span><span id="t11_5" class="t s6_5">Footnote added: Surgical intervention may be an option for select patients with disease that does not respond to induction chemotherapy. </span>
<span id="t12_5" class="t s5_5">ORPH-A </span>
<span id="t13_5" class="t s6_5">• </span><span id="t14_5" class="t s8_5" data-mappings='[[15,"fi"]]'>Footnote 7 modiﬁed: "...In general, the use of concurrent systemic therapy/RT carries a high toxicity burden; </span><span id="t15_5" class="t s6_5">altered fractionation or </span><span id="t16_5" class="t s6_5">multiagent </span>
<span id="t17_5" class="t s8_5">chemotherapy will likely further increase the toxicity burden..." (Also for HYPO-A 1 of 2, GLOT-A 1 of 2, ADV-A 1 of 2, OCC-A 1 of 2, OCC-A 2 of 2, </span>
<span id="t18_5" class="t s6_5">SALI-A) </span>
<span id="t19_5" class="t s5_5">ORPH-B </span>
<span id="t1a_5" class="t s6_5">• Page has been extensively revised. </span>
<span id="t1b_5" class="t s5_5">HYPO-2 </span>
<span id="t1c_5" class="t s6_5">• </span><span id="t1d_5" class="t s8_5" data-mappings='[[42,"fi"]]'>Treatment of primary and neck option, modiﬁed: Partial laryngopharyngectomy (open or endoscopic) + ipsilateral or bilateral neck dissection </span><span id="t1e_5" class="t s9_5">± </span>
<span id="t1f_5" class="t s6_5">hemithyroidectomy, and pretracheal and ipsilateral paratracheal lymph node dissection </span>
<span id="t1g_5" class="t s4_5">Global Changes </span>
<span id="t1h_5" class="t s6_5">• References have been updated throughout the guidelines. </span>
<span id="t1i_5" class="t s6_5">• Contrast recommendation added to all instances of MRI: MRI with </span><span id="t1j_5" class="t s9_5">and without </span><span id="t1k_5" class="t s6_5">contrast. </span>
<span id="t1l_5" class="t s6_5">• Contrast recommendation added to all instances of CT or MRI: CT </span><span id="t1m_5" class="t s9_5">(with contrast) </span><span id="t1n_5" class="t s6_5">or MRI (with </span><span id="t1o_5" class="t s9_5">and without </span><span id="t1p_5" class="t s6_5">contrast) of primary and neck. </span>
<span id="t1q_5" class="t s6_5">• </span><span id="t1r_5" class="t s8_5" data-mappings='[[26,"fi"]]'>All instances of IMRT modiﬁed: IMRT </span><span id="t1s_5" class="t s9_5">(preferred) </span>
<span id="t1t_5" class="t s6_5">• </span><span id="t1u_5" class="t s8_5" data-mappings='[[55,"fi"]]'>All instances of the following statement have been modiﬁed as such: Proton therapy may be considered when normal tissue constraints cannot be met </span>
<span id="t1v_5" class="t s6_5">by photon-based therapy</span><span id="t1w_5" class="t s9_5">, or when photon-based therapy causes compromise of standard radiation dosing to tumor or postoperative volumes. </span>
<span id="t1x_5" class="t s6_5">• </span><span id="t1y_5" class="t s8_5" data-mappings='[[13,"fi"],[61,"fi"]]'>Footnote modiﬁed: H&amp;P should include documentation and quantiﬁcation (pack years smoked) of tobacco use history, </span><span id="t1z_5" class="t s9_5">as well as alcohol use and </span>
<span id="t20_5" class="t s9_5">counseling</span><span id="t21_5" class="t s6_5">. All patients who currently smoke should be advised to quit smoking, and those who formerly smoked should be advised to remain abstinent </span>
<span id="t22_5" class="t s6_5">from smoking. For additional cessation support, refer to the Patient/Provider Smoking Cessation and Treatment Resources in the NCCN Guidelines for </span>
<span id="t23_5" class="t s6_5">Smoking Cessation. </span>
<span id="t24_5" class="t s6_5">• </span><span id="t25_5" class="t s8_5" data-mappings='[[13,"fi"],[95,"ff"],[128,"fi"]]'>Footnote modiﬁed: Image-guided (ultrasound [US] or CT) needle biopsy of cystic neck nodes may oﬀer better diagnostic yield than ﬁne-needle </span>
<span id="t26_5" class="t s6_5">aspiration (FNA) by palpation alone for initial diagnosis in this setting. </span><span id="t27_5" class="t s9_5">For unresectable or metastatic disease where there is a plan for systemic therapy, </span>
<span id="t28_5" class="t s9_5">a core biopsy would allow for ancillary immune-genomic testing. </span>
<span id="t29_5" class="t s5_5">Continued </span>
<span id="t2a_5" class="t sa_5">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
